Ken Griffin's position in Myriad Genetics is currently worth $80.5 Thousand. That's 0.00% of their equity portfolio (4313th largest holding). The first Myriad Genetics trade was made in Q2 2013. Since then Ken Griffin bought shares 55 more times and sold shares on 55 occasions. The investor's estimated purchase price is $410 Thousand, resulting in a loss of 80%.